EUVIMEDEUVIMED entdecken
Open Access

CHCHD2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma: Insights from pan‑cancer multi‑omics and functional studies

Zikai Xu, Jie Shen, Yizhou Lin, Haotian Shi, Cong Zhang, Zhengwei Zhang, Xiaoyu Zhou, Zheng Yang

Oncology Reports · 2026

DOI: 10.3892/or.2026.9213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2026. Verfasst von Zikai Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Adenocarcinoma of Lung, Lung Neoplasms, Mitochondrial Proteins. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorAdenocarcinoma of LungLung NeoplasmsMitochondrial ProteinsTranscription FactorsDNA-Binding ProteinsHumansPrognosisAnimalsMiceGene Expression Regulation, NeoplasticCell ProliferationFemaleMaleCell Line, TumorXenograft Model Antitumor AssaysTumor MicroenvironmentCell MovementApoptosisMiddle AgedGene Expression ProfilingUp-Regulation

Stichwörter der Autor:innen

CHCHD2LUADTMEdrug sensitivitypan‑cancer analysisstemness

Substanzen

Biomarkers, TumorMitochondrial ProteinsCHCHD2 protein, humanTranscription FactorsDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.
  • Medical School of Nantong University, Nantong, Jiangsu 226001, P.R. China.
  • Department of Pharmacy, Affiliated Hospital of Nantong University, Pharmacy School of Nantong University, Nantong, Jiangsu 226001, P.R. China.

Zitieren

APA

Xu, Z., Shen, J., Lin, Y., Shi, H., Zhang, C., Zhang, Z., Zhou, X., & Yang, Z. (2026). CHCHD2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma: Insights from pan‑cancer multi‑omics and functional studies. Oncology Reports. https://doi.org/10.3892/or.2026.9213

Vancouver

Xu Z, Shen J, Lin Y, Shi H, Zhang C, Zhang Z, et al. CHCHD2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma: Insights from pan‑cancer multi‑omics and functional studies. Oncology Reports. 2026. doi:10.3892/or.2026.9213

BibTeX
@article{Xu2026,
  author = {Xu, Zikai and Shen, Jie and Lin, Yizhou and Shi, Haotian and Zhang, Cong and Zhang, Zhengwei and Zhou, Xiaoyu and Yang, Zheng},
  title = {CHCHD2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma: Insights from pan‑cancer multi‑omics and functional studies},
  journal = {Oncology Reports},
  year = {2026},
  doi = {10.3892/or.2026.9213}
}
Kostenlos starten →